Primary cell culture testing is a core in vitro laboratory technique in which living cells are isolated directly from animal or human tissue and cultivated under controlled conditions for biological safety evaluation, cytotoxicity screening, and functional studies. Accredited third-party laboratories conduct these tests in accordance with internationally recognized standards such as ISO 10993-5, GB/T 16886.5, ASTM F813, and USP Chapter 87 to support medical device registration, pharmaceutical development, vaccine production, and biomedical research. This article explains the technical principles, sample types, testing items, methods, and typical applications of primary cell culture testing.
Technical Overview
Primary cell culture testing refers to the isolation of cells directly from freshly excised living tissue, followed by their cultivation in vitro on appropriate growth substrates and culture media. Because primary cells are newly derived from the donor organism, they closely preserve the morphology, metabolism, receptor expression, and functional behavior of the tissue of origin. This distinguishes them from continuous (immortalized) cell lines, which have undergone genetic adaptation and may no longer reflect physiological responses.
Primary cell culture is both a testing platform and a subject of evaluation. As a platform, it is used to assess the biological reactivity and cytotoxicity of medical devices, biomaterials, pharmaceuticals, and chemicals, in alignment with ISO 10993-5 (Tests for in vitro cytotoxicity), the GB/T 16886.5 national standard adopted in China, ASTM F813 and ASTM F895 direct contact methodologies, and USP Chapter 87 biological reactivity test protocols. As a subject of evaluation, primary cultures are characterized for viability, proliferation kinetics, sterility, and suitability for downstream uses such as virus propagation and drug metabolism studies.
A typical primary cell culture workflow includes tissue procurement and transport, aseptic dissection and washing, mechanical or enzymatic dissociation, seeding into culture vessels, incubation at 37 °C in a humidified 5% CO₂ atmosphere, medium exchange, monitoring of morphology and confluence, and subculture or harvest. Rigorous quality controls—sterility testing, mycoplasma screening, viability assessment, and passage-number limitation—are applied throughout the process to ensure the reliability and reproducibility of results.
Testing Samples
Medical Devices and Biomaterials
Test articles include sterile single-use devices, implants, wound dressings, dental materials, catheters, syringes, infusion sets, packaging materials, adhesives, and tissue-engineering scaffolds. Samples may be evaluated directly as coupons placed onto cell monolayers or indirectly as polar and non-polar extracts prepared according to ISO 10993-12 extraction ratios.
Animal-Derived and Human Tissue Specimens
Primary cultures are routinely established from chick embryo fibroblasts, primary rabbit kidney cells, primary monkey kidney cells, bovine testicular cells, porcine or rodent hepatocytes, and human tissues obtained from surgical resection, placenta, umbilical cord, or peripheral blood (peripheral blood mononuclear cells and stem-cell-derived cultures). Tissue provenance, donor health status, and ethical approvals must be documented.
Biopharmaceutical and Biological Products
Viral vaccines, immune globulins, blood products, monoclonal antibodies, gene therapy vectors, and recombinant protein preparations are tested on susceptible primary cell substrates to detect adventitious (extraneous) agents, in accordance with pharmacopoeial requirements and ICH Q5A(R2) guidance on viral safety evaluation.
Chemicals, Cosmetics, and Consumer Products
Extracts of cosmetic formulations, disinfectants, detergents, food-contact materials, textiles, tobacco products, and electronic-cigarette aerosol condensates are screened for in vitro cytotoxicity as an alternative or supplement to animal testing.
Testing Items
Primary cell culture testing typically encompasses the following evaluation items:
- Cell morphology observation and qualitative degeneration scoring (grading of reactivity from Grade 0 to Grade 3 per ISO 10993-5)
- Quantitative in vitro cytotoxicity (MTT, XTT, CCK-8/WST-1, neutral red uptake, resazurin reduction, ATP luminescence)
- Cell viability and membrane integrity (trypan blue exclusion, LDH leakage, propidium iodide staining)
- Cell proliferation and growth curve determination, including population doubling time and contact inhibition behavior
- Colony formation efficiency and clonogenic capacity
- Cell attachment, spreading, and migration assays on material surfaces
- Sterility testing (bacterial and fungal culture) and endotoxin determination (LAL method)
- Mycoplasma detection by culture method, DNA staining, or PCR
- Cell identity and purity verification using morphological, biochemical, or immunocytochemical markers
- Karyotype analysis and genetic stability monitoring across passages
- Adventitious agent testing: virus isolation and propagation, cytopathic effect (CPE) observation, hemadsorption and hemagglutination assays
- Functional assays on specialized primary cells, such as hepatic metabolic competence or endothelial barrier function
Testing Methods
Tissue Dissociation and Culture Initiation
Tissue is dissected under aseptic conditions, minced, and dissociated either enzymatically—using trypsin-EDTA, collagenase, dispase, or hyaluronidase—or mechanically, or by the tissue explant outgrowth method in which small tissue blocks adhere to the vessel surface and release migratory cells. Isolated cells are filtered, counted, assessed for initial viability, and seeded at defined densities in complete culture medium supplemented with serum and antibiotics where appropriate.
Direct Contact Test
Following the approach of ASTM F813 and ISO 10993-5, a sterile test sample is placed directly onto a semi-confluent cell monolayer. After incubation of typically 24 to 48 hours, the cells are examined microscopically for zone extent, lysis, vacuolization, and detachment, and reactivity is graded. This method is suited to materials with diffusible or contact-mediated effects.
Extract (Indirect Contact) Method
Test article extracts are prepared with polar vehicles (e.g., serum-supplemented medium) and, where applicable, non-polar vehicles, using standardized surface-area-to-volume extraction ratios and conditions described in ISO 10993-12. The extracts are applied to cultured cells, and cytotoxicity is quantified after 24 to 48 hours of exposure. Per ISO 10993-5, viability greater than or equal to 70% relative to the negative control indicates the sample is considered non-cytotoxic.
Agar Diffusion and Filter Diffusion Tests
In the agar overlay method, cells are covered with a thin agar layer before the test material is applied, restricting the cells to viability staining rather than migration. In the filter diffusion method, cells grown on a cellulose acetate membrane are placed cell-side-down onto the agar surface and the sample is applied to the filter side. Both methods are useful for evaluating leachable toxicity from solid materials.
Quantitative Colorimetric and Fluorescence Assays
Metabolic activity is measured using MTT or MTS tetrazolium reduction, WST-1/CCK-8 water-soluble tetrazolium salts, neutral red uptake into lysosomes, resazurin (Alamar Blue) reduction, or ATP-dependent luminescence. Cytotoxicity is reported as the percentage of viability relative to untreated or negative-control cells, supported by dose-response curves and IC50 determination where required.
Adventitious Agent and Virus Propagation Methods
Biological products are inoculated onto susceptible primary cell substrates and observed over one to two weeks for cytopathic effects, with blind passage and hemadsorption testing performed to enhance detection sensitivity, consistent with pharmacopoeial monographs and ICH Q5A(R2) viral safety principles.
Applications
Primary cell culture testing is applied across regulatory submissions, product development, and academic research:
- Medical device biocompatibility evaluation for registration in China and international markets, supporting ISO 10993-1 biological evaluation plans and GB/T 16886 series conformity
- Biological safety screening of novel biomaterials, coatings, 3D-printed implants, and biodegradable scaffolds during research and development
- Viral safety assessment of vaccines, blood products, and biotechnology-derived products through adventitious agent testing on primary cell substrates
- Vaccine seed virus propagation and titration using chick embryo fibroblasts and primary kidney cell cultures
- Drug discovery and preclinical toxicology, including hepatotoxicity prediction with primary hepatocytes and species-specific metabolism studies
- Cosmetic and chemical safety testing as an in vitro alternative supporting non-animal testing strategies
- Tissue engineering and regenerative medicine research, including cell-scaffold interaction, differentiation, and biocompatibility studies
- Precision oncology programs using patient-derived primary tumor cultures for individualized drug sensitivity testing
- Academic research into cell physiology, differentiation, senescence, and gene function in a physiologically relevant cellular context
FAQ
What is the difference between primary cell culture and continuous cell line culture?
Primary cells are derived directly from tissue and retain near-physiological characteristics, normal karyotype, and a finite lifespan, typically usable for only a limited number of passages. Continuous cell lines, such as L929 or V79 fibroblasts, are immortalized, grow indefinitely, and are easier to standardize, but may have altered genotype and phenotype. ISO 10993-5 permits the use of either, provided the cell type is justified and appropriately sensitive.
Which standards govern primary cell culture-based cytotoxicity testing?
The principal standards are ISO 10993-5 and its Chinese counterpart GB/T 16886.5 for in vitro cytotoxicity, ISO 10993-12 for sample preparation and reference materials, ASTM F813 and ASTM F895 for direct contact cell culture evaluation, and USP Chapter 87 for biological reactivity of plastics and elastomeric materials in vitro.
What is the acceptance criterion for cytotoxicity results?
Under ISO 10993-5, a quantitative result showing cell viability of 70% or greater relative to the negative control indicates the test sample is considered non-cytotoxic. Qualitative morphological grading from 0 (none) to 3 (severe) is used as a complementary measure.
How long does a primary cell culture test take?
Test duration depends on the method: extract-based cytotoxicity assays usually require 3 to 10 working days including extraction and incubation, while culture establishment from fresh tissue, adventitious agent testing, or virus isolation studies may extend from two to four weeks.
What are the sample submission requirements?
Test articles should be supplied sterile or in a condition representative of final use, with sufficient quantity to satisfy the ISO 10993-12 extraction ratio or direct contact coverage area. Fresh tissue specimens must be transported promptly in appropriate sterile transport medium under validated temperature conditions, accompanied by donor and ethical documentation.
Why must primary cultures be limited in passage number?
Primary cells undergo senescence and gradual phenotypic drift with each division. To maintain physiological relevance and reproducibility, testing is generally performed at early passages, commonly the primary culture (P0) up to the third passage (P3), with passage number recorded in the test report.